Skip to main content
. Author manuscript; available in PMC: 2017 May 25.
Published in final edited form as: J Vitreoretin Dis. 2017 Jan 26;1(1):65–74. doi: 10.1177/2474126416683299

Figure 7.

Figure 7

Correlation between the number of prior anti-VEGF injections before dual therapy with the dexamethasone intravitreal implant and an anti-VEGF agent and the change in central foveal thickness after the first combined treatment. A best-fitted linear regression curve and Pearson correlation were determined and demonstrated correlation with Pearson correlation coefficient (r=0.375).